First-in-Human Percutaneous Transcatheter Tricuspid Valve Replacement With a Novel Valve

The surgical intervention to treat isolated severe tricuspid regurgitation (TR) is challenging due to the severe TR patients’ high-risk profile, hence associated with a high complication rate. Herein, we describe a first-in-human percutaneous deployment of a novel transcatheter prosthetic xenograft...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaturi, Mordehay, Vaknin-Assa, Hana, Shapira, Yaron, Perl, Leor, Levi, Amos, Koren, Arnon, Kornowski, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387838/
https://www.ncbi.nlm.nih.gov/pubmed/34471878
http://dx.doi.org/10.1016/j.jaccas.2021.06.014
Descripción
Sumario:The surgical intervention to treat isolated severe tricuspid regurgitation (TR) is challenging due to the severe TR patients’ high-risk profile, hence associated with a high complication rate. Herein, we describe a first-in-human percutaneous deployment of a novel transcatheter prosthetic xenograft valve to treat severe TR. (Level of Difficulty: Advanced.)

Ejemplares similares